Skip to main content
Clinical Trials/NCT03836547
NCT03836547
Completed
N/A

Feasibility of a Multi Component Intervention in Patients With Severe Dyspnea and Obesity

Mayo Clinic3 sites in 1 country28 target enrollmentDecember 19, 2019

Overview

Phase
N/A
Intervention
Not specified
Conditions
COPD
Sponsor
Mayo Clinic
Enrollment
28
Locations
3
Primary Endpoint
Breathlessness
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Researchers are trying to test the effectiveness and feasibility of a multicomponent lifestyle intervention to support weight loss decreases dyspnea in obese people with chronic lung disease and clinically significant breathlessness.

Detailed Description

Patient will be randomized to a 12-week intervention that uses the Weight watchers lifestyle program online, a Garmin Fitness Tracker, blue tooth scale and receive health coaching vs a wait-list control group.

Registry
clinicaltrials.gov
Start Date
December 19, 2019
End Date
September 30, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Roberto P. Benzo

Principal Investigator

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Breathlessness

Time Frame: baseline to 12 weeks

Chronic Respiratory Questionnaire Dyspnea

Secondary Outcomes

  • Percent Body Fat using InBody 770 Scale(baseline to 12 weeks)
  • Lean Body Mass (lbs.)using InBody 770 Scale(baseline to 12 weeks)
  • Weight using InBody 770 Scale(baseline to 12 weeks)
  • Skeletal Muscle Mass (lbs.) using InBody 770 Scale(baseline to 12 weeks)
  • Body Mass Index using InBody 770 Scale(baseline to 12 weeks)
  • Mindful Eating(baseline to 12 weeks)
  • Exercise Capacity(baseline to 12 weeks)
  • Sleep Efficiency(baseline to 12 weeks)
  • Sleep Time Measures(baseline to 12 weeks)
  • Daily Steps(baseline to 12 weeks)
  • Daily Sedentary Time(baseline to 12 weeks)
  • Daily Physical Activity(baseline to 12 weeks)
  • Disease specific quality of life(baseline to 12 weeks)

Study Sites (3)

Loading locations...

Similar Trials